Providers
DANA™ is an FDA cleared suite of cognitive and psychological assessments that measures subtle and acute changes in cognitive resilience and speed to aid in the assessment of an individual’s medical or psychological state.
It provides a wealth of data – from single glance top level scores to intensively detailed trial by trial data – and gives an over-time, visual representation of a person’s cognitive development side-by-side with psychological test scores.
DANA has exceptional sensitivity, reproducibility, and controls for training and practice effects. It is HIPAA compliant and available for both Android and iOS devices. DANA is also reimbursable by federal and commercial payers for medically necessary instances that are ordered by a qualified healthcare professional.
Use Cases
To learn more about specific applicable use cases, see the details below
General Health
DANA provides tangible measures to determine the efficacy of treatment plans while increasing overall practice revenue.
Cognitive Rehab
Concussion treatment to improvement in daily life after stroke, DANA captures reliable data quickly to aid in recovery.
Behavioral Health
Psychologists and cognitive health experts use DANA to evaluate and monitor treatment and improvement/decline.
Use Cases
Under the existing FDA-Clearance, DANA is available and medically necessary for broad use in many specialties.